F1000Research (Sep 2023)

Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]

  • Moetemri Zied,
  • Samira Mhamdi,
  • Ghedira Hela,
  • Aida Ayadi,
  • Selsabil Daboussi,
  • Samia Essebaa,
  • Chiraz Aichaouia

Journal volume & issue
Vol. 12

Abstract

Read online

Idiopathic chronic eosinophilic pneumonia (ICEP) is a rare interstitial lung disease of unknown cause. It usually responds well to systemic corticosteroid therapy, but relapses are frequent. We describe two cases of 21- and 27-year-old patients, presenting with dyspnea. The diagnosis of steroid-relapsing and steroid-dependent ICEP was made respectively. Mepolizumab was prescribed to both patients. This treatment resulted in successful long-term disease management with much fewer side effects than a traditional corticosteroid therapy.

Keywords